Erectile dysfunction links to cardiovascular disease-defining the clinical value

Area of Science:

• Cardiology
• Urology
• Preventive Medicine

Background:

• Cardiovascular disease (CVD) is the leading global cause of death, affecting men earlier than women.
• Erectile dysfunction (ED) shares risk factors with CVD and independently predicts future cardiovascular events.
• Subclinical atherosclerosis precedes vascular ED by over a decade and ED precedes clinical CVD by 2-5 years.

Purpose of the Study:

• To review the evidence linking ED with subclinical and clinical CVD.
• To outline current guidelines on using ED assessment for CVD prevention.
• To propose a framework for integrating ED into CVD risk assessment for middle-aged men.

Main Methods:

• Literature review of studies on ED and CVD.
• Analysis of current clinical guidelines and recommendations.
• Development of a proposed clinical framework.

Main Results:

• ED is a significant early indicator of underlying cardiovascular risk.
• Early detection of ED can identify men at high risk for future CVD.
• Current guidelines offer opportunities for ED assessment in CVD prevention strategies.

Conclusions:

• ED serves as a critical, often early, warning sign for CVD.
• Incorporating ED screening into routine care can enhance CVD prevention efforts.
• A systematic approach to ED assessment can help mitigate the global burden of CVD.